Jpmorgan Chase & CO Ideaya Biosciences, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 330,593 shares of IDYA stock, worth $6.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
330,593
Previous 274,693 20.35%
Holding current value
$6.58 Million
Previous $7.06 Million 23.29%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$16.38 - $26.0 $915,642 - $1.45 Million
55,900 Added 20.35%
330,593 $5.42 Million
Q4 2024

Feb 12, 2025
BUY
$24.79 - $31.98 $4.83 Million - $6.23 Million
194,913 Added 244.31%
274,693 $7.06 Million
Q3 2024

Dec 26, 2024
BUY
$30.37 - $43.05 $365,320 - $517,848
12,029 Added 17.75%
79,780 $2.53 Million
Q3 2024

Nov 08, 2024
BUY
$30.37 - $43.05 $365,320 - $517,848
12,029 Added 17.75%
79,780 $2.53 Million
Q2 2024

Dec 26, 2024
SELL
$34.37 - $43.46 $413,436 - $522,780
-12,029 Reduced 15.08%
67,751 $2.38 Million
Q2 2024

Aug 12, 2024
SELL
$34.37 - $43.46 $866,777 - $1.1 Million
-25,219 Reduced 27.13%
67,751 $2.38 Million
Q1 2024

Dec 26, 2024
BUY
$34.2 - $47.13 $451,098 - $621,644
13,190 Added 16.53%
92,970 $4.08 Million
Q1 2024

May 10, 2024
SELL
$34.2 - $47.13 $804,657 - $1.11 Million
-23,528 Reduced 20.2%
92,970 $4.08 Million
Q4 2023

Dec 26, 2024
BUY
$24.59 - $35.83 $902,895 - $1.32 Million
36,718 Added 46.02%
116,498 $4.14 Million
Q4 2023

Feb 12, 2024
BUY
$24.59 - $35.83 $91,671 - $133,574
3,728 Added 3.31%
116,498 $4.14 Million
Q3 2023

Nov 14, 2023
BUY
$21.07 - $29.77 $46,543 - $65,761
2,209 Added 2.0%
112,770 $3.04 Million
Q2 2023

Aug 11, 2023
BUY
$13.33 - $25.53 $988,259 - $1.89 Million
74,138 Added 203.55%
110,561 $2.6 Million
Q1 2023

May 18, 2023
BUY
$13.49 - $18.72 $457,715 - $635,169
33,930 Added 1361.01%
36,423 $500,000
Q1 2023

May 11, 2023
SELL
$13.49 - $18.72 $343,941 - $477,285
-25,496 Reduced 91.09%
2,493 $34,000
Q4 2022

Feb 13, 2023
BUY
$14.47 - $18.17 $81,393 - $102,206
5,625 Added 25.15%
27,989 $509,000
Q3 2022

Nov 14, 2022
BUY
$9.24 - $15.79 $12,095 - $20,669
1,309 Added 6.22%
22,364 $334,000
Q2 2022

Aug 11, 2022
BUY
$8.28 - $13.88 $8,255 - $13,838
997 Added 4.97%
21,055 $291,000
Q1 2022

May 11, 2022
BUY
$11.18 - $24.02 $43,266 - $92,957
3,870 Added 23.91%
20,058 $224,000
Q4 2021

Feb 10, 2022
SELL
$20.95 - $26.88 $180,044 - $231,006
-8,594 Reduced 34.68%
16,188 $383,000
Q3 2021

Nov 12, 2021
BUY
$17.26 - $27.08 $427,737 - $671,096
24,782 New
24,782 $632,000

Others Institutions Holding IDYA

# of Institutions
212
Shares Held
80.3M
Call Options Held
80.3K
Put Options Held
30.5K
View Full List

About IDEAYA Biosciences, Inc.

IDYA Quotes by TradingView
  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $956M
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email